Dr. David Lawson, MD is a board certified oncologist in Atlanta, Georgia. He is currently licensed to practice medicine in Georgia. He is affiliated with Emory University Hospital, Emory University Hospital Midtown, and Grady Memorial Hospital.
Clinical Specialties & Interests
Oncology: General Oncology
Education & Medical Training
Emory University School of Medicine Grady Health System
Certifications & Licensure
GA State Medical License 1975 - 2015 American Board of Internal MedicineInternal Medicine American Board of Internal MedicineMedical Oncology
Awards, Honors, & Recognition
America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009 Atlanta Magazine: Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009, 2007, 2005 America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005 Register to See 1 More
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2011 Jan 01 Awasthi, S.,Lenz, H.,Koehler, S.C.,Christensen, S.D.,Lewis, K.D.,Lawson, D.H.,Kuzel, T.M.,Logan, T.F.,Flaherty, L.E.,Flynn, P.J.,Ernstoff, M.S.,Khushalani, N.I.,Koon, H.B.,Olencki, T.E.,Belani, C.P.,Tarhi... IL-2 Neuropsychiatric Symptoms: Mechanism and Prevention Start of enrollment: 2006 Jan 01 Bruce, E.C.,Hill, C.,Lawson, D.,Miller, A.,Musselman, D.L. Phase II Trial of Depsipeptide (NSC 630176) in Advanced Malignant Melanoma Start of enrollment: 2005 Jan 01 Agarwala, S.S.,Lawson, D.H. A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and Start of enrollment: 1999 Dec 01 Lawson, D.H.,Margolin, K.A.
Publications & Presentations
PubMed Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. Carvajal, R. D.,Sosman, J. A.,Quevedo, J. F.,Milhem, M. M.,Joshua, A. M.,Kudchadkar, R. R.,Linette, G. P.,Gajewski, T. F.,Lutzky, J.,Lawson, D. H.,Lao, C. D.,Flynn, P....; JAMA. 2014 Jun 19. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Kaufman, H. L.,Kirkwood, J. M.,Hodi, F. S.,Agarwala, S.,Amatruda, T.,Bines, S. D.,Clark, J. I.,Curti, B.,Ernstoff, M. S.,Gajewski, T.,Gonzalez, R.,Hyde, L. J.,Lawson, ...; Nat Rev Clin Oncol. 2013 Oct. The Impact of Escitalopram on IL-2-induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings. Musselman, D.,Royster, E. B.,Wang, M.,Long, Q.,Trimble, L. M.,Mann, T. K.,Graciaa, D. S.,McNutt, M. D.,Freda Auyeung, N. S.,Oliver, L.,Lawson, D. H.,Miller, A. H.; Neuropsychopharmacology. 2013 Sep. 1 citation Register to See 59 More
Pharmacokinetics And Toxicity Of High Dose Methotrexate With Leucovorin RescueNational Center For Research Resources 1985 - 1985 Radioimmunoassay In The Evaluation Of Response To Hypophysectomy In MelanomaNational Center For Research Resources 1985 - 1985
Aetna Choice POS II Aetna HMO BCBS Blue Card PPO BCBS Georgia Blue Choice HMO BCBS Georgia BlueChoice Option POS BCBS New Mexico PPO CIGNA HMO CIGNA Open Access CIGNA PPO First Health PPO Great West PPO Humana ChoiceCare Network PPO Lovelace Health Plan PPO Multiplan PHCS PPO Multiplan PPO Presbyterian Commercial United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Dr. David Lawson, Dr. David Lawson, MD, Dr. D Lawson, Dr. David H Lawson